ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT) (CAMAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02873884
Recruitment Status : Unknown
Verified August 2016 by Martine LANGEARD, University Hospital, Caen.
Recruitment status was:  Not yet recruiting
First Posted : August 22, 2016
Last Update Posted : August 22, 2016
Sponsor:
Information provided by (Responsible Party):
Martine LANGEARD, University Hospital, Caen

Brief Summary:
The first aim of this study is to test the effect of the case management on the evolution of therapeutic alliance in patients with first episode psychosis in comparison with traditional nursing. The second aim is to test the effect of case management on nurses' well-being in comparison with traditional nursing. The third objective aims to show if therapeutic alliance is associated with insight in patients and with clinical and demographic data.

Condition or disease Intervention/treatment
Psychotic Disorders Behavioral: Case-management

Study Type : Observational [Patient Registry]
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)
Study Start Date : October 2016
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : October 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
case-management
Patients will meet the case-manager 5 times per month during 1h30 in community living
Behavioral: Case-management
traditional nursing
Patients will meet the case-manager 2 times per month during 1h00 in hospital



Primary Outcome Measures :
  1. Work alliance inventory [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Birchwood insight scale [ Time Frame: 6 months ]
  2. Scale to assess Unawareness of Mental Disorder [ Time Frame: 6 months ]
  3. Well-being at work scale [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
First episode psychosis patients
Criteria

Inclusion Criteria:

  • Age between 16 and 30 years
  • First episode psychosis diagnosis according to DSM-5 criteria

Exclusion Criteria:

  • Lees of 16 years or more than 30 years
  • Not fulfilling DSM-5 criteria for first episode psychosis
  • Any treatment with the psychologist or the psychiatrist of the team

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02873884


Contacts
Contact: Laurent Lecardeur, PhD lecardeur@cyceron.fr

Sponsors and Collaborators
University Hospital, Caen

Responsible Party: Martine LANGEARD, Principal Investigator, University Hospital, Caen
ClinicalTrials.gov Identifier: NCT02873884     History of Changes
Other Study ID Numbers: CAMAT
First Posted: August 22, 2016    Key Record Dates
Last Update Posted: August 22, 2016
Last Verified: August 2016

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders